Previous 10 | Next 10 |
June 24, 2024 Biodexa Pharmaceuticals PLC Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP) Overall 75% Non-progression Rate at 12 Months Median Decrease in Overall Polyp Burden at 12 Month...
13 June 2024 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline...
June 10, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona B...
2024-06-06 16:17:51 ET More on Biodexa Pharmaceuticals Biodexa rallies 80% on positive Phase 2 data for eRapa Biodexa shares rally 126% on rapamycin licensing deal Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals Read the full article on Seeki...
CARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating familial adenomatous polyposis (FAP), a mainly genetic disease of the lower GI tract for which there is currently no reme...
2024-05-23 08:24:59 ET Losers: Barnes & Noble Education ( BNED ) -38% . MGO Global ( MGOL ) -29% . Cytokinetics CYTK -15% announces proposed offering of shares . VF Corp. VFC -13% after Q4 earnings release . Tango Therapeutics TNGX ...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 33.8% to $0.0788 on volume of 1,221,538,672 shares Akoustis Technologies Inc. (AKTS) rose 128.8% to $0.3151 on volume of 536,119,838 shares Crown Electrokinetics Corp. (CRKN) rose 3.1% t...
A look at the top 10 most actives in the United States Akoustis Technologies Inc. (AKTS) rose 254.9% to $0.4887 on volume of 265,314,772 shares Greenwave Technology Solutions Inc. (GWAV) rose 2.9% to $0.0606 on volume of 147,993,224 shares Crown Electrokinetics Corp. (CRKN) fell 17.8% to ...
2024-05-22 08:55:00 ET More on Biodexa Pharmaceuticals Biodexa rallies 80% on positive Phase 2 data for eRapa Biodexa shares rally 126% on rapamycin licensing deal Read the full article on Seeking Alpha For further details see: Biodexa Pharmaceuticals rec...
May 22, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises Proceeds Cover Year 1 eRapa Phase 3 Obligations, Unlocking Twice that Amount in Non-dilutive Grant Fundin...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.62%Change Percent:
Biodexa Pharmaceuticals PLC-ADR Company Name:
BDRX Stock Symbol:
NASDAQ Market:
Biodexa Pharmaceuticals PLC-ADR Website:
July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage ...
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innov...
2024-07-12 06:42:00 ET 3 Top Tips for Trading Penny Stocks During High Market Volatility Trading penny stocks during periods of high market volatility can be both challenging and rewarding. One crucial tip is to maintain a well-structured trading plan. Establish clear entry and exit...